Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Divestments (2016 - 2024)

Historic Divestments for Surgery Partners (SGRY) over the last 7 years, with Q4 2024 value amounting to $600000.0.

  • Surgery Partners' Divestments rose 5000.0% to $600000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $4.6 million for FY2024, which is 22857.14% up from last year.
  • Per Surgery Partners' latest filing, its Divestments stood at $600000.0 for Q4 2024, which was up 5000.0% from $400000.0 recorded in Q4 2023.
  • Surgery Partners' Divestments' 5-year high stood at $11.5 million during Q1 2022, with a 5-year trough of $400000.0 in Q4 2023.
  • For the 4-year period, Surgery Partners' Divestments averaged around $3.4 million, with its median value being $1.2 million (2022).
  • Per our database at Business Quant, Surgery Partners' Divestments crashed by 7592.59% in 2022 and then skyrocketed by 5000.0% in 2024.
  • Surgery Partners' Divestments (Quarter) stood at $5.4 million in 2021, then crashed by 75.93% to $1.3 million in 2022, then tumbled by 69.23% to $400000.0 in 2023, then skyrocketed by 50.0% to $600000.0 in 2024.
  • Its Divestments was $600000.0 in Q4 2024, compared to $400000.0 in Q4 2023 and $1.0 million in Q3 2023.